Chronic medication does not affect hyperactive error responses in obsessive-compulsive disorder

Psychophysiology. 2010 Sep;47(5):913-20. doi: 10.1111/j.1469-8986.2010.00988.x. Epub 2010 Mar 8.

Abstract

Patients with obsessive-compulsive disorder (OCD) show an increased error-related negativity (ERN), yet previous studies have not controlled for medication use, which may be important given evidence linking performance monitoring to neurotransmitter systems targeted by treatment, such as serotonin. In an examination of 19 unmedicated OCD patients, 19 medicated OCD patients, 19 medicated patient controls without OCD, and 21 unmedicated healthy controls, we found greater ERNs in OCD patients than in controls, irrespective of medication use. Severity of generalized anxiety and depression was associated with ERN amplitude in controls but not patients. These data confirm previous findings of an exaggerated error response in OCD, further showing that it cannot be attributed to medication. The absence in patients of a relationship between ERN amplitude and anxiety/depression, as was found in controls, suggests that elevated error signals in OCD may be disorder-specific.

MeSH terms

  • Adult
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Data Interpretation, Statistical
  • Electroencephalography
  • Female
  • Humans
  • Hypnotics and Sedatives / therapeutic use
  • Male
  • Obsessive-Compulsive Disorder / drug therapy*
  • Obsessive-Compulsive Disorder / psychology*
  • Psychiatric Status Rating Scales
  • Psychomotor Performance / drug effects*
  • Reaction Time / drug effects
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Young Adult

Substances

  • Antidepressive Agents, Tricyclic
  • Hypnotics and Sedatives
  • Serotonin Uptake Inhibitors